You just read:

Castle Creek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for Diacerein 1% Ointment in Treatment of Epidermolysis Bullosa Simplex

News provided by

Castle Creek Pharmaceuticals

Mar 06, 2017, 08:30 ET